Rosenblatt Securities Cuts Synopsys (NASDAQ:SNPS) Price Target to $530.00

Synopsys (NASDAQ:SNPS) had its target price dropped by investment analysts at Rosenblatt Securities from $560.00 to $530.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the semiconductor company’s stock. Rosenblatt Securities’ target price points to a potential upside of 18.00% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and reduced their price objective for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the stock a “buy” rating in a report on Wednesday. JPMorgan Chase & Co. upped their target price on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Finally, Piper Sandler reduced their target price on Synopsys from $520.00 to $430.00 and set a “neutral” rating for the company in a research report on Thursday. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Synopsys currently has an average rating of “Hold” and an average target price of $539.00.

Synopsys Stock Up 1.9%

SNPS opened at $449.17 on Thursday. The business has a 50 day moving average of $472.85 and a 200-day moving average of $479.02. The stock has a market capitalization of $86.04 billion, a price-to-earnings ratio of 56.22, a P/E/G ratio of 3.67 and a beta of 1.12. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. Synopsys has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. During the same quarter in the previous year, the firm posted $3.03 earnings per share. Synopsys’s revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, sell-side analysts anticipate that Synopsys will post 10.64 earnings per share for the current year.

Insider Activity at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last 90 days. 0.62% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Synopsys

A number of large investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Synopsys by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after purchasing an additional 283,677 shares in the last quarter. State Street Corp lifted its position in shares of Synopsys by 0.3% during the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock worth $4,128,317,000 after purchasing an additional 28,532 shares in the last quarter. Morgan Stanley grew its stake in shares of Synopsys by 2.5% during the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock valued at $2,148,491,000 after purchasing an additional 109,917 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Synopsys by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock valued at $2,017,256,000 after purchasing an additional 54,329 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in Synopsys by 238.8% in the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after purchasing an additional 1,990,608 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 results beat consensus — revenue jumped ~65.6% YoY to $2.409B and non‑GAAP EPS of $3.77 topped estimates; company reiterates full‑year revenue midpoint and provided robust FY and Q2 EPS ranges. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Board authorized a replenishment of the repurchase program (up to $2.0B), supporting shareholder returns and offsetting some integration anxieties. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Some analysts remain constructive — Morgan Stanley maintained a Buy and analysts call out solid earnings quality and IP trajectory as catalysts. Synopsys: Strong Earnings Quality … Support Buy Rating
• Neutral Sentiment: Notable option activity — unusually large call buying suggests elevated speculative interest/positioning into or after the print (could magnify intraday moves).
• Negative Sentiment: Guidance and China exposure concerns: Reuters reports Synopsys flagged a more muted near‑term outlook tied to China export restrictions and macro uncertainty, which pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
• Negative Sentiment: Debt & integration risk from the large acquisition remains in focus — coverage highlights ~$13.5B in debt and questions about digesting the multibillion acquisition, keeping some investors cautious. Synopsys Carries $13.5 Billion in Debt Into Its Most Consequential Earnings Yet
• Negative Sentiment: Market reaction: several reports note SNPS “slid” despite the beat — investors appear to be weighing forward risks (China, deal debt/integration) more heavily than the quarter’s upside. Synopsys slides despite Q1 results demonstrating 65% revenue surge

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.